Markets:

Overview

News

Currencies

International

Treasuries

AbCellera Biologics Inc. - Common Shares (NQ:ABCL)

3.610 +0.040 (+1.12%)

Streaming Delayed Price Updated: 3:35 PM EDT, Mar 11, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about AbCellera Biologics Inc. - Common Shares

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

AbCellera to Report First Quarter 2024 Financial Results on May 7, 2024

April 03, 2024

From AbCellera Biologics Inc.

Via Business Wire

The 7 Best Penny Stocks to Buy in Q2 2024 ↗

March 27, 2024

Discover seven penny stocks to buy primed for significant gains in Q2 2024. Don't miss out on these picks or your portfolio could suffer.

Via InvestorPlace

AbCellera to Present at the Bloom Burton Healthcare Conference on April 16, 2024

March 19, 2024

From AbCellera Biologics Inc.

Via Business Wire

AbCellera to Collaborate with Biogen to Discover Therapeutic Antibodies for Neurological Conditions

March 11, 2024

From AbCellera Biologics Inc.

Via Business Wire

Recap: AbCellera Biologics Q4 Earnings ↗

February 20, 2024

Via Benzinga

Recap: These 7 Artificial Intelligence (AI) Stock Categories Had Returns From +2 To +15% In February ↗

March 06, 2024

This article is a recap of how 7 artificial intelligence stock categories did in February, and YTD, compared to each other to help you make prudent investment decisions accordingly.

Via Talk Markets

Topics Artificial Intelligence

AbCellera Announces Four Presentations on T-Cell Engagers at AACR 2024

March 05, 2024

From AbCellera Biologics Inc.

Via Business Wire

AI-Powered Drug Discovery Stocks Index Up 9% In February; Remains Down 8% YTD ↗

March 04, 2024

Grand View Research says the global

Via Talk Markets

3 Highly Rated Biotech Stocks to Buy for 300% Gains ↗

February 26, 2024

Biotech stocks like those discussed here have the potential to produce 300% returns and benefit from high analyst ratings.

Via InvestorPlace

AbCellera Announces Resignation of Board Member

February 23, 2024

From AbCellera Biologics Inc.

Via Business Wire

AbCellera to Present at Upcoming Investor Conferences in March

February 22, 2024

From AbCellera Biologics Inc.

Via Business Wire

AbCellera Biologics (ABCL) Q4 2023 Earnings Call Transcript ↗

February 20, 2024

ABCL earnings call for the period ending December 31, 2023.

Via The Motley Fool

Topics Earnings

AbCellera Reports Full Year 2023 Business Results

February 20, 2024

From AbCellera Biologics Inc.

Via Business Wire

Earnings Scheduled For February 20, 2024 ↗

February 20, 2024

Companies Reporting Before The Bell • Barclays (NYSE:BCS) is likely to report quarterly earnings at $0.36 per share on revenue of $7.38 billion.

Via Benzinga

These 9 AI Stock Categories Performed From +18% To -4% Last Week ↗

February 19, 2024

A synopsis of the performances of each of the 9 different artificial intelligence stock categories last week, and YTD, along with a description of what makes up each category and the stocks included in...

Via Talk Markets

Topics Artificial Intelligence

AI-Powered Drug Discovery Stocks Index Up 18% Last Week, Led By BioXcel Therapeutics ↗

February 19, 2024

The AI-powered drug discovery market is projected to grow at a 30% CAGR between now and 2030, with annual sales in excess of $50 billion anticipated. An AI drug discovery revolution is underway.

Via Talk Markets

Topics Artificial Intelligence

AbCellera to Report Full Year 2023 Financial Results on February 20, 2024

January 23, 2024

From AbCellera Biologics Inc.

Via Business Wire

4 Magnificent Healthcare Stocks to Buy in 2024 and Beyond ↗

January 16, 2024

Healthcare stocks have underperformed in 2023, but that is expected to change this year.

Via The Motley Fool

3 Growth Stocks That Could Go Parabolic in 2024 ↗

January 15, 2024

These innovation-oriented companies could take flight this year.

Via The Motley Fool

AI-Focused Drug Discovery Stocks Index Up 26% In December ↗

December 29, 2023

With the promise of lower costs and shorter development timelines, AI-enabled drug discovery holds massive potential to increase the accessibility of drugs and to treat presently incurable conditions.

Via Talk Markets

AbCellera to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 10, 2024

December 20, 2023

From AbCellera Biologics Inc.

Via Business Wire

AI-Focused Drug Discovery Stocks Index Up 10.6% Last Week ↗

December 17, 2023

A new study concludes that the AI method of drug discovery is up to 250 times more efficient than the traditional method.

Via Talk Markets

Topics Artificial Intelligence

AI Meets Biotech: 3 Top Stocks Transforming Medical Science ↗

December 16, 2023

The AI revolution is bringing big gains to biotechnology, including drugs, antibodies, and synthetic biology.

Via InvestorPlace

Topics Artificial Intelligence

The 10 Stocks Using AI To Develop New Drugs Were Up 4%, On Average, Last Week ↗

December 11, 2023

If, as Morgan Stanley postulates, a $50 billion AI drug discovery revolution is underway, here are 10 publicly-traded micro- and small-cap clinical stage pharma companies that are embracing AI to...

Via Talk Markets

Topics Artificial Intelligence

Micro/Small Cap Companies Using AI In Drug Discovery Up 35% In November ↗

December 06, 2023

The AI method is up to 250 times more efficient than the traditional method of drug discovery. reducing timelines for drug discovery, increasing accuracy of efficacy and safety predictions.

Via Talk Markets

Topics Artificial Intelligence

AbCellera to Present at the Piper Sandler 35th Annual Healthcare Conference on November 30, 2023

November 16, 2023

From AbCellera Biologics Inc.

Via Business Wire

AbCellera Presents New Data on Two T-Cell Engager Programs at SITC 2023

November 03, 2023

From AbCellera Biologics Inc.

Via Business Wire

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

November 03, 2023

Via Benzinga

AbCellera Biologics (ABCL) Q3 2023 Earnings Call Transcript ↗

November 03, 2023

ABCL earnings call for the period ending September 30, 2023.

Via The Motley Fool

Topics Earnings

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

November 02, 2023

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.